The decision by Novo Nordisk to discontinue the insulin pens will force patients to revert to syringes, complicating diabetes care for millions of people.
US Food and Drug Administration (FDA) regulations allow human drug compounding — in which licensed pharmacists or physicians ...
Weight loss drugs are incredibly sought-after, but they’re also often difficult to obtain due to limited insurance coverage ...
Understanding the right dose of Ozempic for you can feel a bit confusing, especially if you're just getting started. While ...
One of these candidate drugs is ALIA-1758, expected to significantly reduce cerebral amyloid burden with a low antibody dose, ...